Associate medical professor of biochemistry and pharmacology. His laboratory develops nitric oxide- and hydrogen sulfide-releasing compounds (NOSH-NSAIDs) for the prevention and treatment of colon, pancreatic, and ER-negative breast cancers.
Associate professor in the Departments of Pathology and Molecular & Cellular Biology. Her lab studies the Ly6 gene family in TGF-β signaling and immune escape, with a focus on triple-negative breast cancer and targeted therapy resistance.